These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 20849835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cystatin C levels are positively correlated with both Abeta42 and tau levels in cerebrospinal fluid in persons with Alzheimer's disease, mild cognitive impairment, and healthy controls.
    Sundelöf J, Sundström J, Hansson O, Eriksdotter-Jönhagen M, Giedraitis V, Larsson A, Degerman-Gunnarsson M, Ingelsson M, Minthon L, Blennow K, Kilander L, Basun H, Lannfelt L.
    J Alzheimers Dis; 2010; 21(2):471-8. PubMed ID: 20555147
    [Abstract] [Full Text] [Related]

  • 3. The CST3 BB genotype and low cystatin C cerebrospinal fluid levels are associated with dementia in Lewy body disease.
    Maetzler W, Schmid B, Synofzik M, Schulte C, Riester K, Huber H, Brockmann K, Gasser T, Berg D, Melms A.
    J Alzheimers Dis; 2010; 19(3):937-42. PubMed ID: 20157249
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.
    Helisalmi S, Väkevä A, Hiltunen M, Soininen H.
    Dement Geriatr Cogn Disord; 2009; 27(4):318-21. PubMed ID: 19293566
    [Abstract] [Full Text] [Related]

  • 7. Cystatin C in cerebrospinal fluid as a biomarker of ALS.
    Tsuji-Akimoto S, Yabe I, Niino M, Kikuchi S, Sasaki H.
    Neurosci Lett; 2009 Mar 06; 452(1):52-5. PubMed ID: 19444952
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Brain-derived neurotrophic factor gene polymorphisms in Japanese patients with sporadic Alzheimer's disease, Parkinson's disease, and multiple system atrophy.
    Nishimura M, Kuno S, Kaji R, Kawakami H.
    Mov Disord; 2005 Aug 06; 20(8):1031-3. PubMed ID: 15838855
    [Abstract] [Full Text] [Related]

  • 11. Contribution of cystatin C gene polymorphisms to cerebral white matter lesions.
    Mitaki S, Nagai A, Sheikh AM, Terashima M, Isomura M, Nabika T, Yamaguchi S.
    Cerebrovasc Dis; 2011 Aug 06; 32(5):489-96. PubMed ID: 22057131
    [Abstract] [Full Text] [Related]

  • 12. Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease.
    Holmberg B, Rosengren L, Karlsson JE, Johnels B.
    Mov Disord; 1998 Jan 06; 13(1):70-7. PubMed ID: 9452329
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease.
    Ryberg H, Söderling AS, Davidsson P, Blennow K, Caidahl K, Persson LI.
    Neurochem Int; 2004 Jul 06; 45(1):57-62. PubMed ID: 15082222
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Decreased chloride levels of cerebrospinal fluid in patients with amyotrophic lateral sclerosis.
    Watanabe S, Kimura T, Suenaga K, Wada S, Tsuda K, Kasama S, Takaoka T, Kajiyama K, Takeda M, Yoshikawa H.
    J Neurol Sci; 2009 Oct 15; 285(1-2):146-8. PubMed ID: 19595376
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases.
    Hozumi I, Hasegawa T, Honda A, Ozawa K, Hayashi Y, Hashimoto K, Yamada M, Koumura A, Sakurai T, Kimura A, Tanaka Y, Satoh M, Inuzuka T.
    J Neurol Sci; 2011 Apr 15; 303(1-2):95-9. PubMed ID: 21292280
    [Abstract] [Full Text] [Related]

  • 19. Genetic analysis of the cystatin C gene in familial and sporadic ALS patients.
    Watanabe M, Jackson M, Ikeda M, Mizushima K, Amari M, Takatama M, Hirai S, Ikeda Y, Shizuka-Ikeda M, Okamoto K.
    Brain Res; 2006 Feb 16; 1073-1074():20-4. PubMed ID: 16443201
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.